ARM: AXILLARY REVERSE MAPPING ? A PROSPECTIVE TRIAL TO STUDY RATES OF LYMPHEDEMA AND REGIONAL RECURRENCE AFTER SENTINEL LYMPH NODE BIOPSY AND SENTINEL LYMPH NODE BIOPSY FOLLOWED BY AXILLARY LYMPH NODE DISSECTION WITH AND WITHOUT AXILLARY REVERSE MAPPING

Brief Summary

Type:
Breast Cancer

Study Type:
Prevention

Phase:
III

ClinicalTrials.gov Identifier:
NCT03927027

Study #:
STUDY00144676

Start Date:
Mar 05, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03927027

View Complete Trial Details & Eligibility at ClinicalTrials.gov